US Edition
Ten year study confirms effectiveness of two-week radiotherapy for prostate cancer
- Swedish researchers presented at ESTRO 2025 that a two-and-a-half-week radiotherapy regime treats localized prostate cancer as effectively as the traditional eight-week schedule.
- The research, prompted by the challenges posed by lengthy radiotherapy regimens on patients and healthcare systems, included a large Phase III trial involving 1,200 participants diagnosed with localized prostate cancer at intermediate to high risk.
- After ten years, the short-course treatment achieved 72% failure-free survival and 81% overall survival, comparable to 65% and 79%, respectively, for the standard course, with similar safety and side effect profiles.
- Trial leaders Nilsson and Gunnlaugsson reported that administering a reduced number of larger radiation doses within a condensed treatment schedule is just as effective as the conventional method, while also offering patients greater convenience and the possibility of reduced healthcare expenses.
- These results support wider adoption of short-course radiotherapy, improving patient convenience and healthcare efficiency without sacrificing long-term cancer control or safety.
13 Articles
13 Articles
Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer: 10-year follow-up
Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each year. For many patients, radiotherapy is a standard treatment option that offers outcomes comparable to surgery, particularly for localized disease.
By CNN Radio Argentina Carlos Silva, Medical Director of the Argentine League for the Fight Against Cancer, MN 62,549, spoke about the importance of early detection of prostate cancer. On CNN Primera Maña, he stated that “more than 12,000 cases are diagnosed each year in Argentina and it accounts for 20.4% of all diagnosed cancers. It is the third most common but not the most deadly, which is lung cancer.” Regarding risk factors, he explained th…
Gold-standard prostate surgery now available at the Trust | Sandwell and West Birmingham NHS Trust
An innovative treatment for enlarged prostates is now being offered to NHS patients in Sandwell and West Birmingham for the first time with improved recovery times and long-term benefits. Holmium Laser Enucleation of the Prostate, or HoLEP, is a minimally invasive procedure performed under general anaesthetic and involves using a laser to remove parts of the prostate. It is now being performed by urologists at Sandwell and West Birmingham NHS Tr…
Smarter prostate cancer detection via urine
Scientists have discovered specific markers in urine that can signal the presence of prostate cancer. This breakthrough may lead to a simpler and more accurate method for detecting this life threatening disease. Prostate cancer remains one of the leading causes of death among men worldwide. Each year thousands of lives are lost to this illness and millions of new cases are diagnosed. One of the key challenges in diagnosing prostate cancer early …
Coverage Details
Bias Distribution
- 83% of the sources are Center
To view factuality data please Upgrade to Premium
